Primary Health Properties (LON:PHP) Posts Earnings Results

Key Points

• Primary Health Properties reported a quarterly earnings per share (EPS) of GBX 3.50 ($0.05), alongside a negative return on equity of 0.61% and a net margin of 4.84% for the quarter.
• The company's stock is currently priced at GBX 95.25 ($1.28), with a market capitalization of £1.28 billion and a P/E ratio of -148.68.
• Shore Capital has maintained a "buy" rating on Primary Health Properties, indicating confidence in potential growth despite recent financial challenges.

Primary Health Properties (LON:PHP - Get Free Report) posted its quarterly earnings results on Thursday. The real estate investment trust reported GBX 3.50 ($0.05) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Primary Health Properties had a negative return on equity of 0.61% and a negative net margin of 4.84%.

Primary Health Properties Trading Down 0.6%

PHP opened at GBX 95.25 ($1.28) on Friday. Primary Health Properties has a one year low of GBX 85.40 ($1.15) and a one year high of GBX 105.50 ($1.42). The stock has a market capitalization of £1.28 billion, a PE ratio of -148.68, a P/E/G ratio of 5.64 and a beta of 0.41. The business's 50 day moving average price is GBX 98.97 and its 200 day moving average price is GBX 96.10. The company has a debt-to-equity ratio of 96.73, a quick ratio of 0.62 and a current ratio of 0.50.

Wall Street Analysts Forecast Growth

Separately, Shore Capital reiterated a "buy" rating on shares of Primary Health Properties in a report on Monday, May 19th.

Primary Health Properties Company Profile

Primary Health Properties plc is a leading investor in modern primary healthcare properties. The Company acquires or forward funds the development of modern, purpose-built premises that are leased to GP's, government healthcare bodies, pharmacies and other providers of related healthcare services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.